Why digital health IPOs leave other tech in the dust; IBM expands plans for Watson;

News From Around the Web

> Digital health IPOs will leave enterprise technology in the dust, a guest commentary in VentureBeat argues. "The healthcare IT market is ripe for IPOs for several reasons," Owen Tripp, CEO of health IT consulting company Grand Rounds says. "The market is immense, and that word doesn't really come close to representing the opportunity." According to Tripp, data, stability and little reimbursement risk are reasons digital health funding will continue to soar. Article

> Despite controversy, IBM is expanding its plans for Watson, adding 1,500 marketers and engineers to work on the project, which worries some in the health and tech industries. "Part of my problem with the approach that Watson has taken to healthcare is that almost everything that we know about it comes from the marketing and publicity departments," says Peter Szolovits, head of a clinical decision making group in MIT's computer science division, in an article published in MIT Technology Review. "They have been very closed-mouthed about what they are doing." Article

Health Insurance News

> The Centers for Medicare & Medicaid Services broadened contractors' discretionary authority to deny claims related to other denials stemming from prepayment or post-payment review, JDSupra Business Advisor reported. And contractors need not make additional documentation requests (ADR) for related claims before automatically denying them, according to a newly-edited section of the Program Integrity Manual. Article

Health Provider News

> Community benefit programs can help hospitals meet federal requirements to maintain their non-profit status and improve population health, according to a review abstract published in a special issue of the Journal of Health Care for the Poor and Underserved that focused on the Affordable Care Act (ACA). Article

And Finally... I swear, I'll never complain about paying extra for guacamole again! Article

Suggested Articles

The Department of Health and Human Services announced proposed changes to privacy restrictions on patients' substance use treatment records.

An FDA official said the agency is in discussions with multiple stakeholders to create a universal unique medical device identifier to be stored in EHRs.

Virtual care, remote monitoring, telehealth and other technologies have long been on the “nice to have” list for healthcare. But that's changing.